About In Vitro Technologies
In Vitro Technologies is a Healthcare company based in Melbourne (Australia) founded in 2002, and was acquired by CELSIS in June 2006. Distributor of scientific, clinical diagnostic, and medical products. Its chief executive, as recorded, is Jennifer Parsons. Its website invitro.com.au draws about 10 thousand monthly visits. Its focus areas include Medical Device Distributors.
Company details
In Vitro Technologies was founded in 2002 and is headquartered in Melbourne, Australia. Products in scientific, clinical diagnostic, and medical fields are distributed by the company, with operations focused on life sciences, infection control, womens and childrens health, and infrastructure engineering. Distinct business units are maintained to address specific industry requirements, while support services are provided to customers across these sectors.
- Headquarters Melbourne, Australia
- Stage Acquired
- SectorsHealthcare
- Website invitro.com.au
- Social LinkedIn
- Acquired by CELSIS (Jun 2006)
Investors in In Vitro Technologies
In Vitro Technologies has secured backing from 1 investor. Prominent investors backing the company include Celsis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Celsis is engaged in providing home equipment and energy solutions. | celsis.lt |
Investor details for In Vitro Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of In Vitro Technologies
1 people are tracked at In Vitro Technologies (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jennifer Parsons | MD & CEO | Leadership |
Complete people profiles for In Vitro Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of In Vitro Technologies
2 dated milestones of In Vitro Technologies across 4 years, from founding to its latest funding, stage changes and deals.
- Founded In Vitro Technologies is founded.
- Exit Acquired by CELSIS.
Web traffic of In Vitro Technologies
The website of In Vitro Technologies (invitro.com.au) receives about 10.4K visits a month.
- Monthly visits10.4K
▲ 12% vs previous month
Websites whose visitors overlap most with In Vitro Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
culturecollections.org.uk | culturecollections.org.uk | 100% | #680,866 | – | |
metachem.co.uk | metachem.co.uk | 93% | – | ||
| nbsc.com | 92% | View details | |||
| ebioscience.com | 91% | View details | |||
steridium.com | steridium.com | 91% | #12,299,917 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for In Vitro Technologies
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about In Vitro Technologies
In Vitro Technologies was founded in 2002.
In Vitro Technologies is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
Jennifer Parsons is the CEO of In Vitro Technologies, as recorded in our data.
In Vitro Technologies was founded in 2002 and is headquartered in Melbourne, Australia. Products in scientific, clinical diagnostic, and medical fields are distributed by the company, with operations focused on life sciences, infection control, womens and childrens health, and infrastructure engineering. Distinct business units are maintained to address specific industry requirements, while support services are provided to customers across these sectors.
In Vitro Technologies has 1 investor. Key investors include Celsis.
Yes. In Vitro Technologies was acquired by CELSIS in June 2006.